Hellerup, Denmark

Eckhard Niemeier


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eckhard Niemeier

Introduction

Eckhard Niemeier is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases through innovative dosage regimens. His work has led to the development of a patent that addresses specific medical needs.

Latest Patents

Eckhard Niemeier holds a patent for a dosage regimen involving orismilast. This invention is aimed at treating diseases or disorders that can be ameliorated by inhibiting PDE in a subject. The patent also covers the use of orismilast for treating pruritus associated with atopic dermatitis. This innovative approach highlights his commitment to improving patient care through targeted therapies.

Career Highlights

Eckhard Niemeier is associated with Union Therapeutics A/S, where he continues to work on advancing pharmaceutical innovations. His expertise in the field has positioned him as a valuable asset to the company and the broader medical community. With a focus on developing effective treatments, he has contributed to the ongoing evolution of therapeutic options available to patients.

Collaborations

Eckhard has collaborated with notable colleagues, including Morten Otto Alexander Sommer and Jakob Felding. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Eckhard Niemeier's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts exemplify the impact of dedicated inventors in advancing medical science. His work continues to pave the way for improved treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…